- Home
- »
- Healthcare IT
- »
-
Cognitive Assessment And Training In Healthcare Market Report, 2030GVR Report cover
Cognitive Assessment And Training In Healthcare Market (2024 - 2030) Size, Share & Trends Analysis Report By Assessment (Biometrics, Pen & Paper-based Assessment), By Component (Solution, Services), By Application, By Region, And Segment Forecasts
- Report ID: GVR-4-68039-994-2
- Number of Report Pages: 100
- Format: PDF
- Historical Range: 2018 - 2022
- Forecast Period: 2024 - 2030
- Industry: Healthcare
- Report Summary
- Table of Contents
- Segmentation
- Methodology
- Download FREE Sample
-
Download Sample Report
Cognitive Assessment And Training In Healthcare Market Summary
The global cognitive assessment and training in healthcare market size was estimated at USD 5.2 billion in 2023 and is projected to reach USD 26.1 billion by 2030, growing at a CAGR of 27.02% from 2024 to 2030. Rise in incidence of dementia, awareness of cognitive health, and adoption of technologically advanced cognitive Assessment and Training tools are some of the factors driving the market growth.
Key Market Trends & Insights
- The North America cognitive assessment and training in healthcare market held the largest revenue share of over 37.0% in 2023.
- By application, the clinical trials segment held the largest revenue share of over 42.0% in 2023.
- By assessment, the pen & paper-based assessment segment held the largest revenue market share of over 47.0% in 2023.
- By component, the services component held the largest revenue share of more than 50.0% in 2023.
Market Size & Forecast
- 2023 Market Size: USD 5.2 Billion
- 2030 Projected Market Size: USD 26.1 Billion
- CAGR (2024-2030): 27.02%
- North America: Largest market in 2023
The COVID-19 pandemic had a significant influence on cognitive assessment and training with disruptions in hardware components supply chain required for computer-based assessment and training tools.

In the early phase of the pandemic, some countries implemented lockdowns that significantly hampered the ability to perform routine cognitive assessments and medical treatments in hospitals. The market experienced a minor decline for a short span in 2020. However, it is now on a positive trajectory with major signs of recovery.
Application Insights
The clinical trials segment held the majority revenue share of over 42% in 2023 and is expected to retain its position over the forecast period. Clinical drug safety and efficacy testing is extremely difficult when treating the central nervous system. Study teams can improve the success rate of their trials by using cognitive assessments to make quicker and more informed judgments about their potential therapeutic drug. Numerous organizations provide objective assessments and solutions that aid thousands of researchers working on different symptoms and stages of the development of any drug. Market players support clinical trials by providing validated and sensitive computerized cognitive assessments tested rater training and data quality systems.

The screening & diagnostics segment is likely to witness a significant CAGR over the forecast period. Cognitive assessments are ideal as an effective screening tool to support collaboration with neuropsychologists, neurosurgeons, and other specialists to make evidence-based decisions about next-best steps in the treatment of a patient. Neurologists can more effectively pinpoint deficiencies and strengthen help in diagnosis and subsequently monitor recovery as therapy continues with support of a quantitative assessment of a patient's brain health.
Market Dynamics
Demand for online cognitive assessment and training solutions increased during the pandemic due to better access to technology and the adoption of telehealth, thus mitigating losses experienced in initial phase of the pandemic. As neurological impacts have been observed in COVID-19 patients, tracking cognitive capacity has become a crucial activity, thus contributing to market growth.
According to Alzheimer’s Association, more than 153 million individuals will develop dementia by 2050, up from 57 million in 2019. The anticipated increase is mainly due to rising geriatric population. According to data published by the World Health Organization in February 2019, the total geriatric population in the world is anticipated to reach 1.4 billion by 2030.
As mobile technologies become more accessible, they are increasingly being used in cognitive assessment and clinical research for patient recruitment, data collection, symptom monitoring, and health management. Gamification and serious activity for health self-monitoring and management have experienced a significant increase in popularity in healthcare sector. In 2022, the University of Oxford collaborated with Cambridge Cognition for the Impact of Semaglutide in Amyloid Positivity (ISAP) study to provide cognitive assessments.
Numerous apps have been created to train the brain and challenge the brain, and health-related apps make up a significant portion of this industry. For instance, CogniFit is an interactive game and brain-training app designed to help develop up to 22 more skills, including attention, processing speed, concentration, reaction time, and more. It also helps to improve short-term memory.
Regional Insights
North America held the largest revenue share of more than 37.0% in 2023. The increasing prevalence of dementia, adoption of technologically advanced assessment tools, and significant expenditure on cognitive research are some factors attributed to growth of market. There has been a steady growth in the number of patients with cognitive impairment in the region, which fuels demand for cognitive assessment. Government initiatives such as Aging's Alzheimer's Disease Supportive Services Program support state efforts to develop adaptive, comprehensive, and sustainable service delivery systems for patients with Alzheimer's disease. In June 2022, LifeWorks launched an internet-based cognitive behavioral therapy (iCBT) program in Canada & the U.S. to address signs of burnout for workers in healthcare sector.

Asia Pacific is projected to grow at the fastest CAGR during the forecast period due to rise in geriatric population, increasing prevalence of dementia, increasing incidence of sports injuries & trauma leading to cognitive impairment, rapidly expanding healthcare infrastructure, and growing government support. According to Alzheimer's Disease International, it is estimated that around 71 million people in the Asia Pacific are likely to have dementia by 2050. In addition, TALi Digital Limited, a digital health company, signed an advertising & investment agreement with strategic investment firm Brand Capital International (BCI), to launch support programs in India for children’s mental health & wellness.
Assessment Insights
The pen & paper-based assessment segment dominated with a revenue market share of more than 47% in 2023 owing to easy availability and affordability. Although administration time required is more, the assessments offer the advantage of testing more cognitive capabilities. The results of tests, which evaluate different aspects of cognitive functioning including short-term memory, attention, concentration, working memory, visual-spatial ability, reaction time, and information processing speed, can help clinicians gauge severity of a brain injury and cognitive impairment.
Hosted assessment segment is expected to grow at a significant CAGR over the forecast period owing to better access to technology, growing adoption of telehealth, and increasing adoption of mobile technology for gamification in cognitive assessment and training. In addition, computerized cognitive assessments continue to become reimbursable over time using CPT codes due to the latest advancements in neuropsychological testing. Hosted assessment makes it possible for a medical assistant as well as other non-specialized staff members to deliver assessments reliably, potentially assisting neurologists in doing better assessments and treating more patients.
Component Insights
In 2023, services component held a revenue share of more than 50.0% owing to an increase in demand for advanced services offered by market players. Companies are offering services such as training & support, and consulting for rater qualification, training, and management that equip raters to administer scales most efficiently while adhering to the highest standards. For instance, the experimental technique used by Cogstate, a U.S.-based company, removes pointless training, makes use of a tailored eLearning curriculum, lessens the burden of rater certification, and speeds up the commencement of a study.
The solution segment is expected to grow at the fastest CAGR over the forecast period, owing to a rise in the number of technologically advanced solutions offered by market players. Various solutions offered by businesses are digital assessments, data analysis & reporting, and data management. Market players offer online data management solutions in addition to digital cognitive assessment tools for effective data storage and continuing management of data discrepancies. Researchers and healthcare professionals can instantly access the results after uploading cognitive test data, enabling effective review, cleaning, and analysis.
Key Companies & Market Share Insights
The global market for cognitive assessment and training in healthcare remains highly competitive. Key companies are involved in acquisitions, strategic collaborations, and new product launches to withstand the competition. Companies are focusing on implementing strategies, such as new product launches, regional expansion, partnerships, and distribution agreements, to increase their revenue share.
-
For instance, in May 2023, Linus Health, a digital health solution provider, announced the result of its digital cognitive assessment solution study with a commonly used, paper-based cognitive test, the Mini-Mental State Examination (MMSE), in detecting cognitive cases of impairment. This solution helps in the earlier identification of cognitive issues.
-
For instance, in January 2022, Eisai Co., Ltd. announced the launch of CogMate by its Taiwanese and Hong Kong subsidiaries. CogMate is a digital tool for self-assessment of brain health and is expected to be launched in other countries including Singapore.
Key Cognitive Assessment And Training In Healthcare Companies:
- Cambridge Cognition Ltd
- CogniFit Inc
- Cogstate Ltd
- Brain Resource Company
- WIRB-Copernicus Group
- Quest Diagnostics Incorporated
- Signant Health
- Posit Science
- Clario
- Cognetivity Neurosciences
Cognitive Assessment And Training In Healthcare Market Report Scope
Report Attribute
Details
Market size value in 2024
USD 6.2 billion
Revenue forecast in 2030
USD 26.1 billion
Growth rate
CAGR of 27.02% from 2024 to 2030
Base year for estimation
2023
Historical data
2018 - 2022
Forecast period
2024 - 2030
Report updated
November 2023
Quantitative units
Revenue in USD million/billion and CAGR from 2024 to 2030
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Assessment, component, application, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; Saudi Arabia; South Africa; UAE; Kuwait
Key companies profiled
Cambridge Cognition Ltd.; CogniFit Inc.; Cogstate Ltd.; CNS Vital Signs, LLC; Brain Resource Company; WIRB-Copernicus Group; Quest Diagnostics Incorporated; Signant Health; Posit Science; Clario; Cognetivity Neurosciences
Customization scope
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Cognitive Assessment And Training In Healthcare Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global cognitive assessment and training in healthcare market report based on assessment, component, application, and region:

-
Assessment Outlook (Revenue, USD Million, 2018 - 2030)
-
Biometrics Assessment
-
Pen & Paper-based Assessment
-
Hosted Assessment
-
-
Component Outlook (Revenue, USD Million, 2018 - 2030)
-
Solution
-
Assessment
-
Data Analysis & Reporting
-
Data Management
-
Others
-
-
Services
-
Training & Support
-
Consulting
-
-
-
Application Outlook (Revenue, USD Million, 2018 - 2030)
-
Clinical Trials
-
Screening & Diagnostics
-
Brain Training
-
Academic Research
-
-
Regional Outlook (Revenue, USD Million, 2018 - 2030)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Sweden
-
Norway
-
Denmark
-
-
Asia Pacific
-
China
-
Japan
-
India
-
Australia
-
Thailand
-
South Korea
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
-
Middle East and Africa
-
Saudi Arabia
-
South Africa
-
UAE
-
Kuwait
-
-
Frequently Asked Questions About This Report
b. The global cognitive assessment and training in healthcare market size was estimated at USD 5.2 billion in 2023 and is expected to reach USD 6.2 billion in 2024.
b. The global cognitive assessment and training in healthcare market is expected to grow at a compound annual growth rate of 27.02% from 2024 to 2030 to reach USD 26.1 billion by 2030.
b. North America dominated the cognitive assessment & training in healthcare market and held a share of 37.67% in 2022. The increasing prevalence of dementia cases, the adoption of telehealth, increasing awareness of cognitive health, increased competition among market players, and significant expenditure on research on dementia and clinical trials, and advanced technologies are attributed to the market growth.
b. Some of the key players in the global cognitive assessment & training in healthcare market are Cambridge Cognition Ltd.; CogniFit Inc.; Cogstate Ltd.; CNS Vital Signs, LLC; Brain Resource Company; WIRB-Copernicus Group, Quest Diagnostics Incorporated; Signant Health; Posit Science; and Clario, Cognetivity Neurosciences; among others.
b. Key factors contributing to the market growth include the growing geriatric population, increasing incidence of dementia, adoption of telehealth, technologically advanced assessment & training tools.
Share this report with your colleague or friend.
Need a Tailored Report?
Customize this report to your needs — add regions, segments, or data points, with 20% free customization.
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.